Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Recruiting
135 enrolled
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
Recruiting
100 enrolled
Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
Recruiting
200 enrolled
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
Active not recruiting
153 enrolled
RUBIN
Recruiting
2,950 enrolled
Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.
Active not recruiting
160 enrolled
The Role of 18F-FDG-PET for Staging and Prognostication
Completed
200 enrolled
SUMMIT
Completed
227 enrolled
Long-term Follow-up Study of Patients Receiving CAR-T Cells
Recruiting
500 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
Recruiting
45 enrolled
Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma
Completed
39 enrolled
Registry of Older Patients With Cancer
Recruiting
3,000 enrolled
RevlimidPMS
Completed
28 enrolled
A Study to Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction and High Tumor Burden in Participants With Relapsed or Refractory Mantle Cell Lymphoma
Completed
105 enrolled
A Study of Patients With Relapsed/Refractory Mantle Cell Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting
Recruiting
300 enrolled
Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India
Completed
40 enrolled
Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy
Recruiting
300 enrolled
CART-SIE
Recruiting
5,300 enrolled
Preliminary Assessment of [18F]BL40 in PET/CT Scans
Unknown
30 enrolled
PROSECO
Completed
592 enrolled
Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin
Completed
10 enrolled 3 charts
Liquid Biopsy in Mature B-cell Tumors
Recruiting
444 enrolled
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
Completed
174 enrolled
Patient Perspectives in Mantle Cell Lymphoma Clinical Research
Not yet recruiting
500 enrolled
"Don't Eat me" Signal in Hematological Malignancies: CD24 as New Target to Improve Anti-cancer Immunity.
Unknown
30 enrolled
FIRE
Completed
508 enrolled
Zanubrutinib in the Treatment of Recurrent Refractory Mantle Cell Lymphoma
Unknown
30 enrolled
Ibrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged ≤65 Years
Unknown
60 enrolled
Ibrutinib Combined With Bendamustine and Rituximab in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged > 65 Years
Unknown
60 enrolled
ZEVALIN-DUI
Completed
400 enrolled
Study of Bortezomib (BTZ) Treatment on Mantle Cell Lymphoma (MCL) in Chinese Participants
Completed
54 enrolled
MCLRR
Completed
88 enrolled
A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers
Completed
20 enrolled
FABRIC
Unknown
60 enrolled
TLN-Registry
Completed
3,795 enrolled
Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product
Terminated
4 enrolled
Bendamustine Plus Rituximab for Mantle Cell Lymphoma: a Multicenter Retrospective Analysis(BR-MCL)
Unknown
40 enrolled
Lenalidomide Observational Study in Patients With Mantle Lymphoma in Relapse/Refraction. Spanish Programme RRMCL Results.
Unknown
25 enrolled
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Terminated
150 enrolled
Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
Completed
9 enrolled 4 charts
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Terminated
1,000 enrolled
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
Completed
304 enrolled
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
Completed
36 enrolled
BMPB
Unknown
108 enrolled
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Completed
54 enrolled
Blood Samples From Patients on a Clinical Trial to CINV During HSCT
Terminated
9 enrolled
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Completed
41 enrolled
Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma
Completed
17 enrolled
Observational Study for Patients With Newly Diagnosed (MCL) Not Eligible for High-dose Therapy
Completed
73 enrolled